Commentary

Cutting Red Tape

Publish date: October 18, 2012

 

Mr. Tennant works on federal legislative and regulatory health information technology issues at the MGMA-ACMPE. He is also a member of the Board of Directors of the Workgroup for Electronic Data Interchange.

Pages

Recommended Reading

Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
MDedge Hematology and Oncology
Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
MDedge Hematology and Oncology
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
MDedge Hematology and Oncology
Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Frontline Metastatic Soft Tissue Sarcoma (PICASSO III)
MDedge Hematology and Oncology
A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced L-Sarcoma
MDedge Hematology and Oncology
Efficacy and Safety of Masitinib (AB1010) in Comparison to Imatinib in Patients With Gastrointestinal Stromal Tumor
MDedge Hematology and Oncology
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
MDedge Hematology and Oncology
Baseline Factors Trump Response to Therapy in Mastectomy Decisions
MDedge Hematology and Oncology
TURANDOT Revisits Bevacizumab Partners in Metastatic Breast Cancer
MDedge Hematology and Oncology
Can Lapatinib Prevent Brain Metastases from Breast Cancer? Data 'Inconclusive'
MDedge Hematology and Oncology